美国 · SEC FORM 4
Canopy Growth Corp
CGC · Nasdaq · CIK 0001737927 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
21 同一窗口内观察到的 Form 4 交易行
14 sales · 7 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-09-22 · Mongeau Luc.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 27,244,377
- 上期报告
- 27,978,911
- 日均成交量
- 2,090,521
- 回补天数
- 13.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-09-22 | Mongeau Luc | 买入 (P) | Common Shares | 27,469 | USD 1.82 | USD 49,994 | SEC 申报 ↗ |
Form 4 申报证据
25 transaction lines in the latest 365-day window; 182 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Yanofsky Theresa | 卖出 (S) | Common Shares | 14,920 | USD 0.93 | USD 13,876 | SEC 申报 ↗ |
| 2026-09-28 | Lazzarato David Angelo | 卖出 (S) | Common Shares | 22,380 | USD 0.93 | USD 20,813 | SEC 申报 ↗ |
| 2026-09-28 | BAYERN JOSEPH | 卖出 (S) | Common Shares | 3,096 | USD 0.93 | USD 2,879 | SEC 申报 ↗ |
展开近期 Form 4 证据 (25 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Yanofsky Theresa | 卖出 (S) | Common Shares | 14,920 | USD 0.93 | USD 13,876 | SEC 申报 ↗ |
| 2026-09-28 | Lazzarato David Angelo | 卖出 (S) | Common Shares | 22,380 | USD 0.93 | USD 20,813 | SEC 申报 ↗ |
| 2026-09-28 | BAYERN JOSEPH | 卖出 (S) | Common Shares | 3,096 | USD 0.93 | USD 2,879 | SEC 申报 ↗ |
| 2026-09-28 | ATKINS M SHAN | 卖出 (S) | Common Shares | 3,096 | USD 0.93 | USD 2,879 | SEC 申报 ↗ |
| 2026-09-17 | Stewart Thomas Carlton | 卖出 (S) | Common Shares | 25,755 | USD 0.93 | USD 23,952 | SEC 申报 ↗ |
| 2026-08-24 | Stewart Thomas Carlton | 卖出 (S) | Common Shares | 2,231 | USD 1.47 | USD 3,280 | SEC 申报 ↗ |
| 2026-08-24 | Gedeon Christelle | 卖出 (S) | Common Shares | 13,344 | USD 1.47 | USD 19,616 | SEC 申报 ↗ |
| 2026-06-26 | Yanofsky Theresa | 卖出 (S) | Common Shares | 15,054 | USD 0.92 | USD 13,850 | SEC 申报 ↗ |
| 2026-06-26 | Lazzarato David Angelo | 卖出 (S) | Common Shares | 22,674 | USD 0.92 | USD 20,860 | SEC 申报 ↗ |
| 2026-06-26 | BAYERN JOSEPH | 卖出 (S) | Common Shares | 3,197 | USD 0.92 | USD 2,941 | SEC 申报 ↗ |
| 2026-06-26 | ATKINS M SHAN | 卖出 (S) | Common Shares | 3,197 | USD 0.92 | USD 2,941 | SEC 申报 ↗ |
| 2026-06-17 | Yanofsky Theresa | 奖励／授予 (A) | Common Shares | 108,324 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Stewart Thomas Carlton | 卖出 (S) | Common Shares | 9,285 | USD 0.97 | USD 9,006 | SEC 申报 ↗ |
| 2026-06-17 | Stewart Thomas Carlton | 奖励／授予 (A) | Common Shares | 379,018 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Mongeau Luc | 卖出 (S) | Common Shares | 135,231 | USD 0.97 | USD 131,174 | SEC 申报 ↗ |
| 2026-06-17 | Mongeau Luc | 奖励／授予 (A) | Common Shares | 1,056,152 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Lazzarato David Angelo | 奖励／授予 (A) | Common Shares | 162,485 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Gedeon Christelle | 卖出 (S) | Common Shares | 58,994 | USD 0.97 | USD 57,224 | SEC 申报 ↗ |
| 2026-06-17 | Gedeon Christelle | 奖励／授予 (A) | Common Shares | 396,012 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | BAYERN JOSEPH | 奖励／授予 (A) | Common Shares | 108,324 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | ATKINS M SHAN | 奖励／授予 (A) | Common Shares | 108,324 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Mongeau Luc | 卖出 (S) | Common Shares | 9,376 | USD 1.06 | USD 9,939 | SEC 申报 ↗ |
| 2025-12-31 | Yanofsky Theresa | 卖出 (S) | Common Shares | 10,434 | USD 1.13 | USD 11,790 | SEC 申报 ↗ |
| 2025-12-31 | Lazzarato David Angelo | 卖出 (S) | Common Shares | 15,715 | USD 1.13 | USD 17,758 | SEC 申报 ↗ |
| 2025-11-11 | BAYERN JOSEPH | 奖励／授予 (A) | Common Shares | 42,658 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CGC |
| CIK | 0001737927 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2833 Medicinal Chemicals & Botanical Products |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 182 transaction lines from 2020-05-01 to 2026-09-28 1 P purchase lines · 79 S sale lines · 102 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.